Adavosertib is currently undergoing clinical trials to evaluate its safety and efficacy. Several phase I and II trials have shown promising results, particularly in combination with other therapies. Ongoing research aims to better understand the optimal usage of adavosertib, its efficacy across different cancer types, and how to mitigate its side effects.
